Copyright Reports & Markets. All rights reserved.

Global Human Micobiome Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Human Micobiome Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Human Micobiome Market Size Growth Rate by Product
      • 1.4.2 Gastrointestinal Tract Human Micobiome
      • 1.4.3 Urogenital Tract Human Micobiome
    • 1.5 Market by End User
      • 1.5.1 Global Human Micobiome Market Size Growth Rate by End User
      • 1.5.2 Diagnosis
      • 1.5.3 Treatment
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Human Micobiome Market Size
      • 2.1.1 Global Human Micobiome Revenue 2014-2025
      • 2.1.2 Global Human Micobiome Sales 2014-2025
    • 2.2 Human Micobiome Growth Rate by Regions
      • 2.2.1 Global Human Micobiome Sales by Regions
      • 2.2.2 Global Human Micobiome Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Human Micobiome Sales by Manufacturers
      • 3.1.1 Human Micobiome Sales by Manufacturers
      • 3.1.2 Human Micobiome Sales Market Share by Manufacturers
      • 3.1.3 Global Human Micobiome Market Concentration Ratio (CR5 and HHI)
    • 3.2 Human Micobiome Revenue by Manufacturers
      • 3.2.1 Human Micobiome Revenue by Manufacturers (2014-2019)
      • 3.2.2 Human Micobiome Revenue Share by Manufacturers (2014-2019)
    • 3.3 Human Micobiome Price by Manufacturers
    • 3.4 Human Micobiome Manufacturing Base Distribution, Product Types
      • 3.4.1 Human Micobiome Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Human Micobiome Product Type
      • 3.4.3 Date of International Manufacturers Enter into Human Micobiome Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Human Micobiome Sales by Product
    • 4.2 Global Human Micobiome Revenue by Product
    • 4.3 Human Micobiome Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Human Micobiome Breakdown Data by End User

    6 North America

    • 6.1 North America Human Micobiome by Countries
      • 6.1.1 North America Human Micobiome Sales by Countries
      • 6.1.2 North America Human Micobiome Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Human Micobiome by Product
    • 6.3 North America Human Micobiome by End User

    7 Europe

    • 7.1 Europe Human Micobiome by Countries
      • 7.1.1 Europe Human Micobiome Sales by Countries
      • 7.1.2 Europe Human Micobiome Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Human Micobiome by Product
    • 7.3 Europe Human Micobiome by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Human Micobiome by Countries
      • 8.1.1 Asia Pacific Human Micobiome Sales by Countries
      • 8.1.2 Asia Pacific Human Micobiome Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Human Micobiome by Product
    • 8.3 Asia Pacific Human Micobiome by End User

    9 Central & South America

    • 9.1 Central & South America Human Micobiome by Countries
      • 9.1.1 Central & South America Human Micobiome Sales by Countries
      • 9.1.2 Central & South America Human Micobiome Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Human Micobiome by Product
    • 9.3 Central & South America Human Micobiome by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Human Micobiome by Countries
      • 10.1.1 Middle East and Africa Human Micobiome Sales by Countries
      • 10.1.2 Middle East and Africa Human Micobiome Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Human Micobiome by Product
    • 10.3 Middle East and Africa Human Micobiome by End User

    11 Company Profiles

    • 11.1 Vedanta
      • 11.1.1 Vedanta Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Vedanta Human Micobiome Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Vedanta Human Micobiome Products Offered
      • 11.1.5 Vedanta Recent Development
    • 11.2 Seres Therapeutics
      • 11.2.1 Seres Therapeutics Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Seres Therapeutics Human Micobiome Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Seres Therapeutics Human Micobiome Products Offered
      • 11.2.5 Seres Therapeutics Recent Development
    • 11.3 Second Genome
      • 11.3.1 Second Genome Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Second Genome Human Micobiome Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Second Genome Human Micobiome Products Offered
      • 11.3.5 Second Genome Recent Development
    • 11.4 Rebiotix
      • 11.4.1 Rebiotix Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Rebiotix Human Micobiome Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Rebiotix Human Micobiome Products Offered
      • 11.4.5 Rebiotix Recent Development
    • 11.5 ActoGeniX
      • 11.5.1 ActoGeniX Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 ActoGeniX Human Micobiome Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 ActoGeniX Human Micobiome Products Offered
      • 11.5.5 ActoGeniX Recent Development
    • 11.6 Enterome BioScience
      • 11.6.1 Enterome BioScience Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Enterome BioScience Human Micobiome Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Enterome BioScience Human Micobiome Products Offered
      • 11.6.5 Enterome BioScience Recent Development
    • 11.7 AvidBiotics
      • 11.7.1 AvidBiotics Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 AvidBiotics Human Micobiome Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 AvidBiotics Human Micobiome Products Offered
      • 11.7.5 AvidBiotics Recent Development
    • 11.8 4D Pharma Research Ltd
      • 11.8.1 4D Pharma Research Ltd Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 4D Pharma Research Ltd Human Micobiome Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 4D Pharma Research Ltd Human Micobiome Products Offered
      • 11.8.5 4D Pharma Research Ltd Recent Development
    • 11.9 Enterologics
      • 11.9.1 Enterologics Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Enterologics Human Micobiome Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Enterologics Human Micobiome Products Offered
      • 11.9.5 Enterologics Recent Development
    • 11.10 Metabogen
      • 11.10.1 Metabogen Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Metabogen Human Micobiome Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Metabogen Human Micobiome Products Offered
      • 11.10.5 Metabogen Recent Development
    • 11.11 Metabiomics
    • 11.12 Ritter Pharmaceuticals
    • 11.13 Osel
    • 11.14 Symberix
    • 11.15 Miomics
    • 11.16 Symbiotix Biotherapies
    • 11.17 MicroBiome Therapeutics LLC

    12 Future Forecast

    • 12.1 Human Micobiome Market Forecast by Regions
      • 12.1.1 Global Human Micobiome Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Human Micobiome Revenue Forecast by Regions 2019-2025
    • 12.2 Human Micobiome Market Forecast by Product
      • 12.2.1 Global Human Micobiome Sales Forecast by Product 2019-2025
      • 12.2.2 Global Human Micobiome Revenue Forecast by Product 2019-2025
    • 12.3 Human Micobiome Market Forecast by End User
    • 12.4 North America Human Micobiome Forecast
    • 12.5 Europe Human Micobiome Forecast
    • 12.6 Asia Pacific Human Micobiome Forecast
    • 12.7 Central & South America Human Micobiome Forecast
    • 12.8 Middle East and Africa Human Micobiome Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Human Micobiome Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Human Micobiome market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Human Micobiome market based on company, product type, end user and key regions.

      This report studies the global market size of Human Micobiome in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Micobiome in these regions.
      This research report categorizes the global Human Micobiome market by top players/brands, region, type and end user. This report also studies the global Human Micobiome market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Vedanta
      Seres Therapeutics
      Second Genome
      Rebiotix
      ActoGeniX
      Enterome BioScience
      AvidBiotics
      4D Pharma Research Ltd
      Enterologics
      Metabogen
      Metabiomics
      Ritter Pharmaceuticals
      Osel
      Symberix
      Miomics
      Symbiotix Biotherapies
      MicroBiome Therapeutics LLC

      Market size by Product
      Gastrointestinal Tract Human Micobiome
      Urogenital Tract Human Micobiome
      Market size by End User
      Diagnosis
      Treatment

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Human Micobiome market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Human Micobiome market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Human Micobiome companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Human Micobiome submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Human Micobiome are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Human Micobiome market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now